UK Pharma Funding Rounds 2024

Every UK Pharma funding round filed in 2024, sourced direct from Companies House filings. Updated weekly.

UK Pharma Funding Rounds 2024

CompanyRaisedRoundDate
Glo Healthcare Uk£53.9M-2026/09/03
Phaim Pharma£165k-2026/02/10
Remedium Capital£132k-2025/07/09
Antev£31kCash and option exercises-2025/04/06
Eliem Therapeutics (Uk)£24k-2025/04/02
Celadon Pharmaceuticals£1.1M-2025/03/04
Antiverse£383kSeed2025/02/19
Celix Pharma£2.5M-2025/02/11
Kaerus Bioscience£705kSeries A2025/02/07
Aurum Biosciences£150k-2025/01/23
Gylden Pharma£840kSeries A2025/01/20
Ducentis Biotherapeutics£3.1M-2025/01/16
My-T Bio£270k-2025/01/15
St Andrews Pharmaceutical Technology£969k-2025/01/14
Noveeda£150k-2025/01/14
Ferryx£103k-2025/01/12
Celex Oncology Innovations£470k-2025/01/03
Astronautx£18.0MSeries A2025/01/03
Grow Group£931kUnspecified non-cash consideration, no new money-2024/12/31
Mitorx Therapeutics£827k-2024/12/19
Rs & Rs Scientific£300k-2024/12/17
Trimtech Therapeutics£6.8MSeed2024/12/17
Actimed Therapeutics£2.5M-2024/12/17
Stablepharma£1.7M-2024/12/17
Flarin Holdings£1.5M-2024/12/13

Sign up to see all uk pharma funding rounds 2024

+127 more rounds

Sign up

More Pharma funding